Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch

Journal of Crohn's and Colitis

Volumn 7, Issue 11, 2013, Pages

  Werner, Lael ^a   Sturm, Andreas ^b   Roggenbuck, Dirk ^c,d   Yahav, Lior ^a   Zion, Tanir ^a   Meirowithz, Elhanan ^a   Ofer, Amos ^a   Guzner Gur, Hanan ^a,e   Tulchinsky, Hagit ^a,b   Dotan, Iris ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Krankenhaus Waldfriede   (Germany)

^d Medipan GmbH   (Germany)

^e Lausitz University of Applied Sciences   (Germany)

Author keywords

Anti GP2; Glycoprotein 2; IPAA; Pouchitis; Serological markers

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN 2 ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROBIOTIC AGENT; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES CULTURE; FEMALE; HUMAN; ILEITIS; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; SCHOOL CHILD;

ACCA; ALCA; AMCA; ANTI-CHITOBIOSIDE CARBOHYDRATE ANTIBODIES; ANTI-GP2; ANTI-LAMINARIBIOSIDE CARBOHYDRATE ANTIBODIES; ANTI-MANNOBIOSIDE CARBOHYDRATE ANTIBODIES; ANTI-SACCHAROMYCES CEREVISIAE ANTIBODIES; ASCA; C-REACTIVE PROTEIN; CD; CROHN'S DISEASE; CRP; FAMILIAL ADENOMATOUS POLYPOSIS; FAP; GLYCOPROTEIN 2; GP2; IBD; ILEAL POUCH ANAL ANASTOMOSIS; INFLAMMATORY BOWEL DISEASES; IPAA; PAB; PANCREATIC (AUTO)-ANTIBODY; PDAI; POUCHITIS; POUCHITIS DISEASE ACTIVITY INDEX; SEROLOGICAL MARKERS; UC; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; COHORT STUDIES; COLITIS, ULCERATIVE; COLONIC POUCHES; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; GPI-LINKED PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; POUCHITIS; PREDICTIVE VALUE OF TESTS; PROCTOCOLECTOMY, RESTORATIVE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84884815661     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.03.009     Document Type: Article

References (45)

1. Molodecky N.A., Soon I.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., Panaccion R., Ghosh H., Barkema H.W., Kaplan G.G. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142:46-54.
2. Dotan I., Fishman S., Dgani Y., Schwartz M., Karban A., Lerner A., Spector L., Shtevi A., Altstock R.T., Dotan N., Halpern Z. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 2006, 131:366-378.
3. Kaul A., Hutfless S., Liu L., Bayless T.M., Marohn M.R., Li X. Serum anti-glycan antibody biomarkers for inflammatory bowel disease diagnosis and progression: a systematic review and meta-analysis. Inflammatory Bowel Diseases 2012, 18:1872-1884.
4. Rieder F., Schleder S., Wolf A., Dirmeier A., Strauch U., Obermeier F., Lopez R., Spector L., Fire E., Yarden J., Rogler G., Dotan N., Klebl F. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior. Inflammatory Bowel Diseases 2010, 16:263-274.
5. Austin G.L., Herfarth H.H., Sandler R.S. A critical evaluation of serologic markers for inflammatory bowel disease. Clinical Gastroenterology and Hepatology 2007, 5:545-547.
6. Demirsoy H., Ozdil K., Ersoy O., Kesici B., Karaca C., Alkim C., Erdem L.K., Onuk M.D., Beyzadeoglu H.T. Anti-pancreatic antibody in Turkish patients with inflammatory bowel disease and first-degree relatives. World Journal of Gastroenterology 2010, 16:5732-5738.
7. Klebl F.H., Bataille F., Huy C., Hofstadter F., Scholmerich J., Rogler G. Association of antibodies to exocrine pancreas with subtypes of Crohn's disease. European Journal of Gastroenterology and Hepatology 2005, 17:73-77.
8. Koutroubakis I.E., Drygiannakis D., Karmiris K., Drygiannakis I., Makreas S., Kouroumalis E.A. Pancreatic autoantibodies in Greek patients with inflammatory bowel disease. Digestive Diseases and Sciences 2005, 50:2330-2334.
9. Lakatos P.L., Altorjay I., Szamosi T., Palatka K., Vitalis Z., Tumpek J., Sipka S., Udvardy M., Dinya T., Lakatos L., Kovacs A., Molnar T., Tulassay Z., Miheller P., Barta Z., Stocker W., Papp J., Veres G., Papp M. Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort. Inflammatory Bowel Diseases 2009, 15:365-374.
10. Stocker W., Otte M., Ulrich S., Normann D., Finkbeiner H., Stocker K., Jantschek G., Scriba P.C. Autoimmunity to pancreatic juice in Crohn's disease. Results of an autoantibody screening in patients with chronic inflammatory bowel disease. Scandinavian Journal of Gastroenterology. Supplement 1987, 139:41-52.
11. Roggenbuck D., Hausdorf G., Martinez-Gamboa L., Reinhold D., Buttner T., Jungblut P.R., Porstmann T., Laass M.W., Henker J., Buning C., Feist E., Conrad K. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease. Gut 2009, 58:1620-1628.
12. Bogdanos D.P., Rigopoulou E.I., Smyk D.S., Roggenbuck D., Reinhold D., Forbes A., Laass M.W., Conrad K. Diagnostic value, clinical utility and pathogenic significance of reactivity to the molecular targets of Crohn's disease specific-pancreatic autoantibodies. Autoimmunity Reviews 2011, 11:143-148.
13. Bogdanos D.P., Roggenbuck D., Reinhold D., Wex T., Pavlidis P., von Arnim U., Forbes A., Conrad K., Laass M.W. Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease. BMC Gastroenterology 2012, 12:102.
14. Suzuki H., Ogawa H., Shibata C., Haneda S., Watanabe K., Takahashi K., Funayama Y., Sasaki I. The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis. Diseases of the Colon and Rectum 2012, 55:330-336.
15. Wu H., Shen B. Pouchitis and pouch dysfunction. Gastroenterology Clinics of North America 2009, 38:651-668.
16. Stocchi L., Pemberton J.H. Pouch and pouchitis. Gastroenterology Clinics of North America 2001, 30:223-241.
17. Shen B. Acute and chronic pouchitis-pathogenesis, diagnosis and treatment. Nature Reviews. Gastroenterology & Hepatology 2012, 9:323-333.
18. Coukos J.A., Howard L.A., Weinberg J.M., Becker J.M., Stucchi A.F., Farraye F.A. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis. Digestive Diseases and Sciences 2012, 57:1544-1553.
19. Tyler A.D., Milgrom R., Xu W., Stempak J.M., Steinhart A.H., McLeod R.S., Greenberg G.R., Cohen Z., Silverberg M.S. Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis. Clinical Gastroenterology and Hepatology 2012, 10:507-512. (e501).
20. Tulchinsky H., Dotan I., Alper A., Brazowski E., Klausner J.M., Halpern Z., Rabau M. Comprehensive pouch clinic concept for follow-up of patients after ileal pouch anal anastomosis: report of 3years' experience in a tertiary referral center. Inflammatory Bowel Diseases 2008, 14:1125-1132.
21. Gionchetti P., Amadini C., Rizzello F., Venturi A., Poggioli G., Campieri M. Diagnosis and treatment of pouchitis. Best Practice & Research. Clinical Gastroenterology 2003, 17:75-87.
22. Sandborn W.J., Tremaine W.J., Batts K.P., Pemberton J.H., Phillips S.F. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clinic Proceedings 1994, 69:409-415.
23. Landy J., Al-Hassi H.O., McLaughlin S.D., Knight S.C., Ciclitira P.J., Nicholls R.J., Clark S.K., Hart A.L. Etiology of pouchitis. Inflammatory Bowel Diseases 2012, 18:1146-1155.
24. Dotan I., Werner L., Vigodman S., Weiss S., Brazowski E., Maharshak N., Chen O., Tulchinsky H., Halpern Z., Guzner-Gur H. CXCL12 is a constitutive and inflammatory chemokine in the intestinal immune system. Inflammatory Bowel Diseases 2010, 16:583-592.
25. Werner L., Paclik D., Fritz C., Reinhold D., Roggenbuck D., Sturm A. Identification of pancreatic glycoprotein 2 as an endogenous immunomodulator of innate and adaptive immune responses. Journal of Immunology 2012, 189:2774-2783.
26. Ferrante M., Henckaerts L., Joossens M., Pierik M., Joossens S., Dotan N., Norman G.L., Altstock R.T., Van Steen K., Rutgeerts P., Van Assche G., Vermeire S. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007, 56:1394-1403.
27. Lu H., Lian L., Navaneethan U., Shen B. Clinical utility of C-reactive protein in patients with ileal pouch anal anastomosis. Inflammatory Bowel Diseases 2010, 16:1678-1684.
28. Gionchetti P., Amadini C., Rizzello F., Venturi A., Poggioli G., Campieri M. Probiotics for the treatment of postoperative complications following intestinal surgery. Best Practice & Research. Clinical Gastroenterology 2003, 17:821-831.
29. Lammers K.M., Vergopoulos A., Babel N., Gionchetti P., Rizzello F., Morselli C., Caramelli E., Fiorentino M., Volk H.D., Campieri M. Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflammatory Bowel Diseases 2005, 11:447-454.
30. Abraham B.P., Kane S. Fecal markers: calprotectin and lactoferrin. Gastroenterology Clinics of North America 2012, 41:483-495.
31. Macpherson A.J., McCoy K.D., Johansen F.E., Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunology 2008, 1:11-22.
32. Suzuki K., Fagarasan S. Diverse regulatory pathways for IgA synthesis in the gut. Mucosal Immunology 2009, 2:468-471.
33. Bonaci-Nikolic B., Spuran M., Andrejevic S., Nikolic M. Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, in patients with gluten-sensitive enteropathy: a possible serological trap. Clinica Chimica Acta 2012, 413:822-823.
34. Conrad K., Roggenbuck D., Reinhold D., Sack U. Autoantibody diagnostics in clinical practice. Autoimmunity Reviews 2012, 11:207-211.
35. Op De Beeck K., Vermeire S., Rutgeerts P., Bossuyt X. Antibodies to GP2, the major zymogen granule membrane glycoprotein, in inflammatory bowel diseases. Gut 2012, 61:162-164. (author reply 164-165).
36. Shen B. Crohn's disease of the ileal pouch: reality, diagnosis, and management. Inflammatory Bowel Diseases 2009, 15:284-294.
37. Tang L.Y., Cai H., Navaneethan U., Boone J.H., Rhodes S.J., Moore L., Rho H., Queener E., Shen B. Utility of fecal and serum anti-Saccharomyces cerevisiae antibodies in the diagnosis of Crohn's disease-like condition of the pouch. International Journal of Colorectal Disease 2012, 27:1455-1463.
38. Dendrinos K.G., Becker J.M., Stucchi A.F., Saubermann L.J., LaMorte W., Farraye F.A. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis. Journal of Gastrointestinal Surgery 2006, 10:1060-1064.
39. Vasiliauskas E.A., Kam L.Y., Karp L.C., Gaiennie J., Yang H., Targan S.R. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000, 47:487-496.
40. Auer I.O., Grosch L., Hardorfer C., Roder A. Ulcerative colitis specific cytotoxic IgG-autoantibodies against colonic epithelial cancer cells. Gut 1988, 29:1639-1647.
41. Ebert E.C., Geng X., Lin J., Das K.M. Autoantibodies against human tropomyosin isoform 5 in ulcerative colitis destroys colonic epithelial cells through antibody and complement-mediated lysis. Cellular Immunology 2006, 244:43-49.
42. Kovvali G., Das K.M. Molecular mimicry may contribute to pathogenesis of ulcerative colitis. FEBS Letters 2005, 579:2261-2266.
43. Melmed G.Y., Fleshner P., Ippoliti A., Papadakis K.A., Dubinsky M., Landers C., Rotter J.I., Targan S.R. Familial history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis. Diseases of the Colon and Rectum 2008, 51:100-108.
44. Hase K., Kawano K., Nochi T., Pontes G.S., Fukuda S., Ebisawa M., Kadokura K., Tobe T., Fujimura Y., Kawano S., Yabashi A., Waguri S., Nakato G., Kimura S., Murakami T., Iimura M., Hamura K., Fukuoka S., Lowe A.W., Itoh K., Kiyono H., Ohno H. Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response. Nature 2009, 462:226-230.
45. Fukuoka S., Freedman S.D., Yu H., Sukhatme V.P., Scheele G.A. GP-2/THP gene family encodes self-binding glycosylphosphatidylinositol-anchored proteins in apical secretory compartments of pancreas and kidney. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:1189-1193.